Bachem Holding AG
BANB.SW
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.82B
Close$
Share Statistics
| Market cap | $6.82 Billion |
|---|---|
| Enterprise Value | $6.97 Billion |
| Dividend Yield | $0.90 (1.12%) |
| Earnings per Share | $1.98 |
| Beta | 0.79 |
| Outstanding Shares | 74,935,540 |
Return
| Return on Equity | 19.71% |
|---|---|
| Return on Assets | 12.16% |
| Return on Invested Capital | 16.78% |
Valuation & Multiples
| P/E Ratio | 40.23 |
|---|---|
| PEG | -17761.41 |
| Price to Sales | 4.45 |
| Price to Book Ratio | 4.21 |
| Enterprise Value to Revenue | 5.04 |
| Enterprise Value to EBIT | 22.94 |
| Enterprise Value to Net Income | 24 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
$0.47
Average shareholder expectationRevenue Estimate
$324.73 M
Average shareholder expectationNext Earnings Call
Expected Date
March 4, 2027
EPS Estimate
$1.58
Average shareholder expectationRevenue Estimate
$614.20 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bachem Holding AG
2,511 employees
CEO: Anne-Kathrin Stoller Bachem Holding AG provides essential products to pharmaceutical and biotechnology companies worldwide, supporting their activities from early research and clinical trials through to commercial manufacturing. The company's primary focus i...